The Influence of Intensive Education and Coaching on Compliance for Oral Ganciclovir in the Prophylaxis of CMV: an Open Randomised Trial
NCT00566072 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21
Last updated 2007-12-06
Summary
21 patients were randomised to receive instructions and coaching or no intervention on the use and intake of ganciclovir. Intake of medication was measured by an electronic pill box. The duration of the study was 100 days.
Conditions
- Cytomegalovirus Infections
Interventions
- BEHAVIORAL
-
instructions and coaching
instructions and coaching or no intervention on the use and intake of ganciclovir
Sponsors & Collaborators
- collaborator INDUSTRY
-
University Hospital, Ghent
lead OTHER
Principal Investigators
-
Isabelle Devolder, MD · University Hospital, Ghent
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-05-31
- Completion
- 2003-05-31
Countries
- Belgium
Study Locations
More Related Trials
-
An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access
NCT00002135 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Pharmacokinetics (PK) and Pharmacodymamics (PD) of Ganciclovir (GCV) in Premature Infants Receiving Treatment for Cytomegalorivus (CMV) Infection
NCT01602614 ·Status: COMPLETED
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Large Intestine in Patients With AIDS
NCT00002273 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Study of the Efficacy and Safety of Maintenance Treatment With Oral Ganciclovir for Newly Diagnosed Cytomegalovirus Retinitis in People With AIDS
NCT00002257 ·Status: COMPLETED ·Phase: NA
-
Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients
NCT00730769 ·Status: COMPLETED ·Phase: PHASE4
-
Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
NCT00002024 ·Status: COMPLETED ·Phase: NA
-
An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children
NCT00002015 ·Status: COMPLETED ·Phase: NA
-
Neonatal CMV-Ganciclovir Follow-up Study
NCT00031421 ·Status: COMPLETED
-
(Val)Ganciclovir TDM in Transplant Recipients
NCT03698435 ·Status: UNKNOWN
-
A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir
NCT00002251 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients
NCT00364052 ·Status: UNKNOWN
-
Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
NCT00004278 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Controlled Study of the Safety and Preventive Efficacy of Oral Ganciclovir When Used in Conjunction With An Intravitreal Ganciclovir Implant in the Treatment of Cytomegalovirus Retinitis
NCT00002134 ·Status: COMPLETED ·Phase: NA
-
A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes
NCT00001062 ·Status: COMPLETED ·Phase: PHASE1
-
Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients With Acute Respiratory Failure and Sepsis
NCT04706507 ·Status: TERMINATED ·Phase: PHASE3
-
Observational Study Comparing the Efficacy of Ganciclovir as a Function of Blood Exposure to the Drug During a Curative or Preemptive Treatment
NCT03088553 ·Status: UNKNOWN
-
A Study of Two Forms of Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
NCT00002330 ·Status: COMPLETED ·Phase: NA
-
Trial to Evaluate Safety and Immunogenicity of a Vaccine Against HCMV
NCT02798692 ·Status: COMPLETED ·Phase: PHASE1
-
Impact of CMV Status on HIV Viral Load Decay
NCT03349359 ·Status: COMPLETED
-
Valganciclovir in Congenital CMV Infants
NCT00031434 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of AZT Plus Ganciclovir in Patients With AIDS and Cytomegalovirus (CMV) Infection
NCT00000995 ·Status: COMPLETED ·Phase: NA
-
Cell Mediated Immunity for Secondary Prophylaxis in CMV SOT Patients
NCT02370758 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine
NCT01357915 ·Status: COMPLETED ·Phase: NA
-
A Randomized Study Comparing the Safety and Efficacy of Two Regimens of Oral Ganciclovir to Intravenous Ganciclovir Maintenance Therapy for Cytomegalovirus Retinitis in People With AIDS Who Have Received Prior Ganciclovir Therapy
NCT00002247 ·Status: COMPLETED ·Phase: NA
-
Determining a Viral Load Threshold for Treating Cytomegalovirus (CMV)
NCT00947141 ·Status: COMPLETED ·Phase: PHASE4